News Contact Us Careers Get E-Mail alerts Search

You are now leaving www.admabiologics.com

The link you have selected will take you outside of ADMA Biologics corporate website. The site you will be entering is intended for U.S. audiences only. Do you wish to continue?

Yes No

News

See below for our most recent and archived news events.

Click below for current and archived news related to the company.

ADMA Biologics Announces Closing of $57.5 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Oct 25, 2021 4:01pm EDT

ADMA Biologics Announces Data Presented at the 2021 ISIRV-WHO Conference

Oct 22, 2021 7:00am EDT

ADMA Biologics Announces Pricing of Public Offering for $50 Million of Common Stock

Oct 21, 2021 9:00am EDT

ADMA Biologics Announces Proposed Public Offering of Common Stock

Oct 20, 2021 4:01pm EDT

ADMA Biologics Announces a Poster Presentation at the 2021 International Society for Influenza and other Respiratory Virus Diseases - World Health Organization Conference

Oct 19, 2021 7:00am EDT

ADMA Biologics Strengthens its Board of Directors with the Appointment of Young T. Kwon, Ph.D.

Oct 18, 2021 7:00am EDT

ADMA Biologics Announces the Presentation of Real-World Experience in the Management of Respiratory Syncytial Virus (RSV) Presented at IDWeek 2021

Oct 04, 2021 7:00am EDT

ADMA Biologics Announces Presentation on Respiratory Viral Infections at IDWeek 2021

Oct 01, 2021 7:00am EDT

ADMA Biologics to Virtually Participate in the Cantor Healthcare Conference

Sep 23, 2021 7:00am EDT

ADMA Biologics Receives FDA Approval for VanRx Aseptic Fill-Finish Machine and Related Operations

Sep 08, 2021 7:00am EDT

1
2
3
4
5
6
7
8
9
10
...22